A clinical research network to improve the management of Monkeypox virus disease

Projektinformationen

MPX-RESPONSE

ID Finanzhilfevereinbarung: 101115188

DOI 10.3030/101115188

EK-Unterschriftsdatum 14 April 2023

Startdatum 5 August 2022

Enddatum 4 August 2026

Finanziert unter

• Health

Gesamtkosten € 11 999 999,30

EU-Beitrag € 11 999 999,30

Koordiniert durch

INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE
France

Leistungen

Documents, reports (2)

Guidelines on how to implement a centralised pharmacovigilance system

Describes how a centralised pharmacovigilance system is implemented

Safety Management Plan

Describes the governance the safety circuit and communication of the trial The safety communication between the trial safety group InsermANRSMIE and Sponsors representatives with the trial committees TCT TSC DSMB will be described